Ikarovec
London, United Kingdom· Est.
Develops gene therapies for neuromuscular diseases using novel viral vector technology.
Private Company
Total funding raised: $3M
About
Develops gene therapies for neuromuscular diseases using novel viral vector technology.
RNA & Gene Therapy
Funding History
1Total raised:$3M
Seed$3M